CT Perfusion as an Imaging Biomarker in Monitoring Response to Neoadjuvant Bevacizumab and Radiation in Soft-Tissue Sarcomas: Comparison With Tumor Morphology, Circulating and Tumor Biomarkers, and Gene Expression
American Journal of Roentgenology - United States
doi 10.2214/ajr.13.12412
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
American Roentgen Ray Society